Works matching IS 15228517 AND DT 2018 AND VI 20 AND IP 9
Results: 24
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1185, doi. 10.1093/neuonc/noy046
- By:
- Publication type:
- Article
Seizure outcomes of supratentorial brain tumor resection in pediatric patients.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1272, doi. 10.1093/neuonc/noy026
- By:
- Publication type:
- Article
Neurosurgeons still wanted.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1150, doi. 10.1093/neuonc/noy081
- By:
- Publication type:
- Article
Population description and clinical response assessment for spinal metastases: the SPINO group report.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1149, doi. 10.1093/neuonc/noy107
- By:
- Publication type:
- Article
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1183, doi. 10.1093/neuonc/nox027
- By:
- Publication type:
- Article
Targeting MIR155HG in glioma: a novel approach.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1152, doi. 10.1093/neuonc/nox095
- By:
- Publication type:
- Article
Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1206, doi. 10.1093/neuonc/nox028
- By:
- Publication type:
- Article
The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1217, doi. 10.1093/neuonc/nox033
- By:
- Publication type:
- Article
Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1263, doi. 10.1093/neuonc/nox007
- By:
- Publication type:
- Article
O-(2-18F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1271, doi. 10.1093/neuonc/now310
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1154, doi. 10.1093/neuonc/nox137
- By:
- Publication type:
- Article
Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1237, doi. 10.1093/neuonc/nox050
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1284, doi. 10.1093/neuonc/nox136
- Publication type:
- Article
Differences in genetic and epigenetic alterations between von Hippel–Lindau disease–related and sporadic hemangioblastomas of the central nervous system.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1228, doi. 10.1093/neuonc/nox034
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1285, doi. 10.1093/neuonc/nox143
- Publication type:
- Article
Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1279, doi. 10.1093/neuonc/nox107
- By:
- Publication type:
- Article
Combining standard clinical blood values for improving survival prediction in patients with newly diagnosed brain metastases—development and validation of the LabBM score.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1255, doi. 10.1093/neuonc/now290
- By:
- Publication type:
- Article
A clinician’s plea to test glioma patients for CMV.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1282, doi. 10.1093/neuonc/nox080
- By:
- Publication type:
- Article
Citation classics in neuro-oncology: assessment of historical trends and scientific progress.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1158, doi. 10.1093/neuonc/nox053
- By:
- Publication type:
- Article
Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1248, doi. 10.1093/neuonc/nox066
- By:
- Publication type:
- Article
Can telomerase activity be unleashed to refine prognosis within ependymoma subgroups?
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1149, doi. 10.1093/neuonc/nox059
- By:
- Publication type:
- Article
Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer’s disease.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1173, doi. 10.1093/neuonc/nox058
- By:
- Publication type:
- Article
Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1195, doi. 10.1093/neuonc/nox017
- By:
- Publication type:
- Article
Absence of CMV viremia in high-grade glioma patients under low dosage glucocorticoid treatment.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1280, doi. 10.1093/neuonc/nox065
- By:
- Publication type:
- Article